Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Weibin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3087-7973; OpenAlex author ID A5100667350. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 3 papers · 2026: 1 paper

Papers 9

  1. IRP1/ARID3A complex promotes pancreatic cancer chemoresistance by suppressing CYGB-related ferroptosis. Last author DOI 10.1016/j.gendis.2025.101866↗
  2. Lymphatic metastasis in pancreatic cancer: from bedside to bench and back. Last author DOI 10.1007/s10555-025-10297-9↗
  3. Nuclear localization of YAP in pancreatic cancer: More players besides Hippo pathway. Last author DOI 10.1016/j.canlet.2025.217864↗
  4. EDC4 enhances multi-drug chemosensitivity in pancreatic cancer via GR50-based profiling. Last author DOI 10.1186/s12935-025-04000-9↗
  5. Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets. Last author DOI 10.1016/j.bbcan.2024.189183↗
  6. STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation. Last author DOI 10.1038/s41419-023-05711-5↗
  7. Pancreatic cancer stemness: dynamic status in malignant progression. Last author DOI 10.1186/s13046-023-02693-2↗
  8. Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment. Co-author DOI 10.1007/s00262-020-02542-7↗
  9. E‑cadherin is downregulated by microenvironmental changes in pancreatic cancer and induces EMT. Co-author DOI 10.3892/or.2018.6528↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bangbo Zhao · 8 shared papers, 2018–2026 · strength 1.73
  2. Yutong Zhao · 7 shared papers, 2023–2026 · strength 1.63
  3. Zeru Li · 7 shared papers, 2023–2026 · strength 1.63
  4. Cheng Yong Qin · 4 shared papers, 2025–2026 · strength 1.01
  5. Tianyu Li · 4 shared papers, 2024–2026 · strength 0.97
  6. Haoyu Shi · 3 shared papers, 2025–2026 · strength 0.78
  7. Yiping Xie · 3 shared papers, 2025–2026 · strength 0.75
  8. Cheng Qin · 2 shared papers, 2023–2024 · strength 0.42
  9. Xiaoying Yang · 2 shared papers, 2023 · strength 0.39
  10. Tianyu Li · 2 shared papers, 2023 · strength 0.39
  11. Yuanyang Wang · 2 shared papers, 2023 · strength 0.39
  12. Lin Chen · 1 shared paper, 2024 · strength 0.23
  13. Cheng‐Feng Qin · 1 shared paper, 2023 · strength 0.19
  14. Yupei Zhao · 2 shared papers, 2018–2020 · strength 0.19
  15. Jun Lü · 1 shared paper, 2018 · strength 0.11
  16. Li Zhou · 1 shared paper, 2020 · strength 0.09
  17. Quan Liao · 1 shared paper, 2020 · strength 0.09
  18. Xiang Zhang · 1 shared paper, 2020 · strength 0.09
  19. Ming Cui · 1 shared paper, 2020 · strength 0.09
  20. Boju Pan · 1 shared paper, 2020 · strength 0.09
  21. Qiaofei Liu · 1 shared paper, 2020 · strength 0.09
  22. Huanwen Wu · 1 shared paper, 2020 · strength 0.09
  23. Ronghua Zhang · 1 shared paper, 2020 · strength 0.09
  24. Junyi Gao · 1 shared paper, 2020 · strength 0.09
  25. Tong Li · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.